Clerical Medical home    Contact us    Careers    Glossary    Accessibility    Sitemap  
Go
Clerical Medical - logo
Media zone home
Press office
News releases
Spokespeople / photogallery
Senior management
Clerical Medical Investment Committee
Company information
Find a media financial adviser


Go to . . .
Group pension zone Group pension zone
Media zone Media zone
Adviser zone Adviser zone
International zone International zone
 
News release  
 

26 January 2009

Year of the rat sees Chinese stock prices fall 65%

  • Chinese stock prices, measured by the Shanghai Index, have declined by 65% over the past year from an index value of 5,521 on 31st December 2007 to 1,912 on 31st December 2008, more than double the fall in UK stock prices (-31%)
  • The decline in Chinese stock prices over the past year was significantly greater than the average fall across the major global stockmarkets (-43%)
  • Over the past year, stock prices in China have fallen by more than their neighbouring countries and by more than the regional average of -49%
  • During the past decade the Chinese Shanghai Index rose by 56% (4.6% pa on average) from an index value of 1,220 on 31st December 1998 to 1,912 on 31st December 2008
  • China has recorded the biggest rise in equity prices of all the major stockmarket across the world in the past decade and is one of only three of the major global stockmarkets to have recorded an overall increase between 1998 and 2008
  • Martin Ellis, chief economist at Clerical Medical, said:
    "The Year of the Rat proved to be a turbulent one for the Chinese stockmarket with stock prices falling by 65% compared to a 43% decline for the average across the major global markets."

    "China was still one of the few major global stockmarkets to emerge from 2008 with equity prices higher than a decade ago, suggesting that it remains one of the most attractive emerging markets for investors."

    Key findings

    Chinese stock prices in 2008

    Chinese equity prices down 65%1 in Year of the Rat
    With China about to enter the Year of the Ox in the Chinese calendar, new research by Clerical Medical shows that stock prices in China in 2008 fell by more than double the decline in UK equity prices. Over the past year, the Shanghai Index has declined by 65% from an index value of 5,521 on 31st December 2007 to 1,912 on 31st December 2008. Over the same period, the FTSE100 fell by 31% from 6,457 to 4,434.

    1Based on the average end month index values across global stockmarkets

    Chinese stock prices hit by crisis of confidence
    The drop in Chinese stock prices was more marked than across any of the other major global markets2. Fears over the impact of a prolonged US recession on the Chinese economy led to a decline in investor confidence with sales of consumer goods, particularly to the US, a key driver of Chinese growth. Additionally, rising inflation and tighter government controls contributed to the sharp fall in Chinese equity prices.

    Stock prices in China underperform major global stockmarkets2 in 2008
    The drop in Chinese stock prices over the past year (-65%) exceeded the decline in all the other major stockmarkets across the world and was significantly greater than the average fall of 43%. Hong Kong recorded the second largest fall (-48%), followed by Australia and France (both -43%).

    Equity prices in China decline faster than the East Asian3 regional average
    Over the past year, stock prices in China (-65%) have fallen by more than their neighbouring countries and by more than the regional average2 of -49%. India recorded the second sharpest decline (-55%) in the region, followed by Indonesia (-51%).

    Chinese stock prices 1998-2008

    Chinese stock prices have risen by 57%1 over the past decade
    Between 1998 and 2008 the Chinese Shanghai Index rose by 57% from an index value of 1,220 on 31st December 1998 to 1,912 on 31st December 2008. In contrast, the FTSE100 fell by 25% over the same period.

    China outperforming the major global stockmarkets2
    The stockmarket in China recorded the highest rate of growth among the major global stock markets over the past decade. Furthermore, China was one of only three of the major global stockmarkets2 to record an increase in equity prices between 1998 and 2008. Hong Kong (43%) and Australia (30%) were the only other major stockmarkets to see equity price growth over the same period. At the other end of the scale, Japanese stock prices fell by 36% over the decade to the end of 2008, while UK equity prices have fallen by a quarter over the same period.

    Chinese stock prices have, however, underperformed the regional average
    Equity prices across East Asia3 have risen by an average of 83% over the decade to 2008. The top performing stock markets in the region were India (267%) and Indonesia (241%), both more than four times the stock price growth recorded in China (57%). The Indian stockmarket has benefited from its status as one of the world's fastest growing economies, while Indonesia benefited from the recent commodity boom. In contrast, equity prices in Taiwan (-28%) and the Philippines (-5%) fell between 1998 and 2008.

    1Based on the average end month index values across global stockmarkets
    2Major global stockmarkets comprise China, Hong Kong, Australia, France, Japan, Germany, USA and UK
    3East Asia comprises Indonesia, India, South Korea, Hong Kong, Philippines, China, Malaysia, Thailand and Taiwan.

    The following is a list of the 18 new Clerical Medical funds, their fund managers and the fund management company they work for. These are not external fund links.

    Table 1: China & Major Global Stockmarkets
    Country Dec-98 Dec-07 Dec-08 1 year 10 year 10yrs %pa
    China 1220 5521 1912 -65% 57% 4.6%
    Hong Kong 10049 27813 14387 -48% 43% 3.7%
    Australia 2813 6421 3659 -43% 30% 2.7%
    France 3943 5614 3218 -43% -18% -2.0%
    Japan 13842 15308 8860 -42% -36% -4.4%
    Germany 5002 8057 4810 -40% -4% -0.4%
    USA 9181 13265 8776 -34% -4% -0.5%
    UK 5883 6457 4434 -31% -25% -2.8%
    Average - - - -43.4% 5.3% 0.1%
    Source: Datastream

    Table 2: China & East Asian Region
    Country Dec-98 Dec-07 Dec-08 1 year 10 year 10yrs %pa
    China 1220 5521 1912 -65% 57% 4.6%
    India 1359 11154 4988 -55% 267% 13.9%
    Indonesia 398 2746 1355 -51% 241% 13%
    Philippines 1969 3622 1873 -48% -5% -0.5%
    Hong Kong 10049 27813 14387 -48% 43% 3.7%
    Thailand 356 858 450 -48% 26% 2.4%
    Taiwan 6418 8506 4591 -46% -28% -3.3%
    South Korea 562 1897 1124 -41% 100% 7.2%
    Malaysia 586 1445 877 -39% 50% 4.1%
    Average - - - -49% 83.3% 5.0%
    Source: Datastream

    EDITORS' NOTES:

    1. The following indices have been used as benchmarks for share prices:

    Country Index
    Australia ASX ALL ORDINARIES 1971 > - PRICE INDEX
    Brazil BRAZIL BOVESPA - PRICE INDEX
    China SHANGHAI SE A SHARE - PRICE INDEX
    France FRANCE CAC 40 - PRICE INDEX
    Germany DAX 30 PERFORMANCE - PRICE INDEX
    Hong Kong HANG SENG - PRICE INDEX
    India INDIA BSE (100) NATIONAL - PRICE INDEX
    Indonesia JAKARTA SE COMPOSITE - PRICE INDEX
    Japan NIKKEI 225 STOCK AVERAGE - PRICE INDEX
    Malaysia KLCI COMPOSITE - PRICE INDEX
    Philippines PHILIPPINE SE I(PSEi) - PRICE INDEX
    Russia RSF EE MT (RUR) INDEX - PRICE INDEX
    South Korea KOREA SE COMPOSITE (KOSPI) - PRICE INDEX
    Taiwan TAIWAN SE WEIGHTED - PRICE INDEX
    Thailand BANGKOK S.E.T. - PRICE INDEX
    UK FTSE 100 - PRICE INDEX
    USA DOW JONES INDUSTRIALS - PRICE INDEX

    2. International indices have been measured in local currency terms and assume a fully hedged currency exposure.

    3. Data is measured as at end month index value. Price indices rather than total return indices have been used for this analysis to obtain a complete data set.

    "This report is prepared from information that we believe is collated with care, however, it is only intended to highlight issues and it is not intended to be comprehensive. We reserve the right to vary our methodology and to edit or discontinue/ withdraw this, or any other report. Any use of this report for an individual's own or third party commercial purposes is done entirely at the risk of the person making such use and solely the responsibility of the person or persons making such reliance. © HBOS plc all rights reserved 2009".

    Return to the news releases page

     
    Please see our legal and privacy statements.
    Issued by Clerical Medical Investment Group Limited. Registered Office 33 Old Broad Street, London EC2N 1HZ. Registered in England and Wales, Registered No. 3196171. Clerical Medical Investment Group Limited is authorised and regulated by the Financial Services Authority. These pages are intended for UK residents only. During this period of transition Clerical Medical is an introducer of Scottish Widows products. The firms are regulated by the Financial Services Authority. Scottish Widows plc. Registered in Scotland No. 199549. Registered Office in the United Kingdom at 69 Morrison Street, Edinburgh EH3 8YF. Telephone: 0845 767 8910.